340 related articles for article (PubMed ID: 14691665)
1. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
Kobayashi N; Okitsu T; Nakaji S; Tanaka N
J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
[TBL] [Abstract][Full Text] [Related]
2. Life support of artificial liver: development of a bioartificial liver to treat liver failure.
Kobayashi N
J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648
[TBL] [Abstract][Full Text] [Related]
3. [Liver-targeted regenerative medicine].
Kobayashi N; Yong C; Tanaka N
Nihon Geka Gakkai Zasshi; 2004 Aug; 105(8):440-4. PubMed ID: 15373220
[TBL] [Abstract][Full Text] [Related]
4. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination.
Totsugawa T; Yong C; Rivas-Carrillo JD; Soto-Gutierrez A; Navarro-Alvarez N; Noguchi H; Okitsu T; Westerman KA; Kohara M; Reth M; Tanaka N; Leboulch P; Kobayashi N
J Hepatol; 2007 Jul; 47(1):74-82. PubMed ID: 17434229
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes.
Nguyen TH; Mai G; Villiger P; Oberholzer J; Salmon P; Morel P; Bühler L; Trono D
J Hepatol; 2005 Dec; 43(6):1031-7. PubMed ID: 16169114
[TBL] [Abstract][Full Text] [Related]
6. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes.
Soto-Gutiérrez A; Kobayashi N; Rivas-Carrillo JD; Navarro-Alvarez N; Zhao D; Okitsu T; Noguchi H; Basma H; Tabata Y; Chen Y; Tanaka K; Narushima M; Miki A; Ueda T; Jun HS; Yoon JW; Lebkowski J; Tanaka N; Fox IJ
Nat Biotechnol; 2006 Nov; 24(11):1412-9. PubMed ID: 17086173
[TBL] [Abstract][Full Text] [Related]
7. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems.
Tsiaoussis J; Newsome PN; Nelson LJ; Hayes PC; Plevris JN
Liver Transpl; 2001 Jan; 7(1):2-10. PubMed ID: 11150414
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of hepatocytes derived from early ES cells and treatment of surgically induced liver failure rats by transplantation.
Tabei I; Hashimoto H; Ishiwata I; Tachibana T; Akahori M; Ohi S; Kubo H; Satou K; Yamazaki Y; Yanaga K; Ishikawa H
Transplant Proc; 2005; 37(1):262-4. PubMed ID: 15808614
[TBL] [Abstract][Full Text] [Related]
9. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo.
Duan Y; Catana A; Meng Y; Yamamoto N; He S; Gupta S; Gambhir SS; Zern MA
Stem Cells; 2007 Dec; 25(12):3058-68. PubMed ID: 17885076
[TBL] [Abstract][Full Text] [Related]
10. Bioartificial liver systems: current status and future perspective.
Park JK; Lee DH
J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796
[TBL] [Abstract][Full Text] [Related]
11. The optimal hepatocyte density for a hollow-fiber bioartificial liver.
Xu Q; Sun X; Qiu Y; Zhang H; Ding Y
Ann Clin Lab Sci; 2004; 34(1):87-93. PubMed ID: 15038673
[TBL] [Abstract][Full Text] [Related]
12. Cre/loxP-based reversible immortalization of human hepatocytes.
Kobayashi N; Noguchi H; Westerman KA; Watanabe T; Matsumura T; Totsugawa T; Fujiwara T; Leboulch P; Tanaka N
Cell Transplant; 2001; 10(4-5):383-6. PubMed ID: 11549058
[TBL] [Abstract][Full Text] [Related]
13. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
Enosawa S; Miyashita T; Fujita Y; Suzuki S; Amemiya H; Omasa T; Hiramatsu S; Suga K; Matsumura T
Cell Transplant; 2001; 10(4-5):429-33. PubMed ID: 11549067
[TBL] [Abstract][Full Text] [Related]
14. [Liver and artificial liver].
Chamuleau RA
Ned Tijdschr Geneeskd; 1998 Jun; 142(23):1300-5. PubMed ID: 9752034
[TBL] [Abstract][Full Text] [Related]
15. Effect of intrasplenic transplantation of immortalized human hepatocytes in the treatment of acetaminophen-induced acute liver failure SCID mice.
Tsuruga Y; Kiyono T; Matsushita M; Takahashi T; Kasai N; Matsumoto S; Todo S
Transplant Proc; 2008 Mar; 40(2):617-9. PubMed ID: 18374145
[TBL] [Abstract][Full Text] [Related]
16. Novel strategies for immortalization of human hepatocytes.
Cascio SM
Artif Organs; 2001 Jul; 25(7):529-38. PubMed ID: 11493273
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte transplantation: clinical and experimental application.
Ohashi K; Park F; Kay MA
J Mol Med (Berl); 2001 Nov; 79(11):617-30. PubMed ID: 11715065
[TBL] [Abstract][Full Text] [Related]
19. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver.
Di Nicuolo G; van de Kerkhove MP; Hoekstra R; Beld MG; Amoroso P; Battisti S; Starace M; di Florio E; Scuderi V; Scala S; Bracco A; Mancini A; Chamuleau RA; Calise F
Xenotransplantation; 2005 Jul; 12(4):286-92. PubMed ID: 15943777
[TBL] [Abstract][Full Text] [Related]
20. Crucial roles of mesodermal cell lineages in a murine embryonic stem cell-derived in vitro liver organogenesis system.
Ogawa S; Tagawa Y; Kamiyoshi A; Suzuki A; Nakayama J; Hashikura Y; Miyagawa S
Stem Cells; 2005 Aug; 23(7):903-13. PubMed ID: 16043458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
